ALKERMES | ALKS - Pe Prix À Revenus





Pe Changement Date
AbbVie 24.03 86.23 2025-12
Acadia Pharmaceuticals 11.61 2.09 2025-12
ALKERMES 19.54 4.64 2025-12
Amgen 25.31 15.82 2025-12
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
Eli Lilly 40.21 9.66 2025-12
Gilead Sciences 15.63 0.08 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 23.62 0.86 2025-12
Malin Corporation 11.81 0.72 2023-06
Merck 13.92 5.08 2025-12
Neurocrine Biosciences 835.47 802.2 2025-12
Otsuka Holdings 12.07 3.16 2025-12
Ovoca Bio 1.83 3.29 2024-06
Pfizer 14.48 5.18 2025-12
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12